Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients

AIDS Research and Treatment - United States
doi 10.1155/2015/938628
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Multicenter Study of Skin Rashes and Hepatotoxicity in Antiretroviral-Naïve HIV-positive Patients Receiving Non-Nucleoside Reverse-Transcriptase Inhibitor Plus Nucleoside Reverse-Transcriptase Inhibitors in Taiwan

PLoS ONE
Multidisciplinary
2017English

HIV-1 Reverse Transcriptase Nucleotide Substitutions in Subtype C–Infected, Drug-Naive, and Treatment-Experienced Patients in South India

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2011English

Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2010English

Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced Patients With HIV Type 1 Infection

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

Maraviroc 150 Mg Daily Plus Lopinavir/Ritonavir, a Nucleoside/Nucleotide Reverse Transcriptase Inhibitor-Sparing Regimen for HIV-infected Naive Patients: 48-Week Final Results of VEMAN Study

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2015English

Nucleoside Reverse Transcriptase Inhibitor Usage and the Incidence of Peripheral Neuropathy in HIV/AIDS Patients

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
2003English

Selection of Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutations in HIV-1 Subtype C: Evidence of Etravirine Cross-Resistance

AIDS
Infectious DiseasesAllergyImmunology
2011English

Non-Nucleoside Reverse Transcriptase Inhibitor Outcomes Among Combination Antiretroviral Therapy-Treated Adults in Botswana

AIDS
Infectious DiseasesAllergyImmunology
2010English

Pharmaceutical, Clinical, and Resistance Information on Doravirine, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV-1 Infection

Drugs in Context
Molecular MedicinePharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy